Andrea Tan

Stock Analyst at Goldman Sachs

(0.3)
# 2673
Out of 5,380 analysts
53
Total ratings
Success rate
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
INSM Insmed
Maintains: Strong Buy
100 112
105.23 6.43% 10 Jun 11, 2025
IOVA Iovance Biotherapeut...
Maintains: Buy
16 8
1.78 349.44% 7 May 12, 2025
TARS Tarsus Pharmaceutica...
Maintains: Neutral
46 51
40.57 25.71% 4 May 5, 2025
DAWN Day One Biopharmaceu...
Maintains: Buy
39 27
6.4 321.88% 6 Mar 25, 2025
SGMT Sagimet Biosciences
Maintains: Neutral
23 6
9.67 -37.95% 5 Jul 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
15.59 98.85% 1 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
3 2
0.54 270.37% 3 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Sell
2
3.67 -45.5% 1 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
17
n/a n/a 1 Nov 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
141.59 13% 1 Nov 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 24
3.62 562.98% 2 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
10 4
1.16 244.83% 2 Jan 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
178 375
281.69 33.13% 1 Dec 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
13
11.19 16.18% 1 Dec 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
n/a n/a 6 Nov 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 4
n/a n/a 2 May 24, 2022